.jpg)
Renowned plastic surgeon Dr. Michael K. Obeng, who was born in Ghana, has said that his method for becoming a billionaire involves not only creating exceptional cosmetics but also establishing a pharmaceutical empire in Ghana, with diversification serving as the main tenet of his approach.
In a TikTok interview conducted for a street-style feature in Beverly Hills (see below), Dr. Obeng—one of the few black cosmetic surgeons in the affluent community—spoke candidly about his path from Ghanaian slums to international renown, including his ambitions to transform Africa's pharmaceutical sector.
Beyond my wildest expectations, how can a child from Ghana's slums reach Beverly Hills? We are the world's top plastic surgeons. It's God," he said.
Dr. Obeng, who gained worldwide recognition in 2021 for successfully extracting Gorilla Glue from an African-American woman's hair, said that he earned his first million dollars at the age of 34.
He has made up to $9 million in a single year and presently runs a private practice in Beverly Hills.
The Harvard-trained physician immediately said, "Marriage—actually, marrying the wrong person," when asked about his worst financial mistake.
Dr. Obeng gave young business owners honest advise, particularly when it came to relationships. He emphasised the importance of his Christian convictions by saying, "If you two don't share the same faith, period, it's not the right person." Do you think that God exists? Yes, exactly. I wouldn't be here if not for God. God desires for everyone of us to flourish. The ultimate source of riches is God.
Relevant Articles
In Ho, Dr. Michael Obeng starts offering free reconstructive surgery.
Gorilla Glue doctor Michael K. Obeng secures deal to build pharmaceutical facility in Ghana
The Ghanaian-American physician who repaired the "Gorilla Glue girl" is Michael Obeng.
However, he thinks that his bold foray into the pharmaceutical production industry would propel him into the billionaire range.
"I want to become a billionaire so that I can work more." diversification. I am now in the midst of establishing the largest pharmaceutical facility in Sub-Saharan Africa in Ghana. And that's what will make me a millionaire," Dr. Obeng said.
The initiative is now under progress in Akwamu, in Ghana's Eastern Region, and is being led by his firm MiKO Pharma in collaboration with Sushen Medicamentos PVT. LTD, situated in India. The Akwamu Traditional Authority has approved 100 acres of land for the facility, which is expected to cost US$50 million to build. The first phase of construction is anticipated to be completed in nine months, having started in July 2022.
When finished, the plant will produce a variety of WHO-GMP-approved generic medications to treat HIV, malaria, cardiovascular disorders, hypertension, diabetes, and pain. The goal is to provide Ghana and West Africa's expanding health needs with reasonably priced and potent medications.
Dr. Obeng just inked a historic contract with Siemens AG, one of the top technological companies in the world, which will greatly advance the project. Siemens has agreed to provide the site's pharmaceutical manufacturing with modern industrial technologies and infrastructure.
"Our team at MiKO Pharma was extremely proud to be in Germany to sign this historic agreement with Siemens," stated Willard Jackson, Executive Partner of MiKO Pharma. "This collaboration aims to revolutionise healthcare in Ghana and establish a new benchmark for pharmaceutical manufacturing in Africa, not just construct facilities."
Sabine Dall'Omo, CEO of Siemens Sub-Saharan Africa, described the deal as a calculated step towards the continent's sustainable healthcare solutions. "We want to make it possible for Africa to produce safe pharmaceutical medications," she said.
It is anticipated that the factory would greatly lessen Ghana's need on imported medications and generate 130 direct employment. "This initiative will significantly enhance healthcare accessibility in the region," said Dr. Obeng.
Currently, only 30% of Ghana's medicine demand is met by domestic pharmaceutical manufacture. The industry is growing, nevertheless. The need for generic medications is expected to propel Ghana's pharmaceutical sales, which were GHS6.6 billion (US$571 million) in 2023 and are expected to reach GHS10.7 billion (US$735 million) by 2028.
Dr. Michael Obeng is well-positioned to become a millionaire and transform Ghana's pharmaceutical industry because to his audacious ideas, strong faith, and worldwide support.
.jpg)
